NeuroMetrix, Inc. (NeuroMetrix) is a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes. The Company is focused on the development of products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with diabetes, carpal tunnel syndrome (CTS), lumbosacral disc disease and spinal stenosis. It markets systems for the performance of nerve conduction studies (NCS) and needle electromyography procedures. The Company markets a variety of consumables and accessories for use with its neurodiagnostic devices. The Company�s initial product for diabetic neuropathy, NC-stat DPNCheck, was launched in September 2011. NC-stat DPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN).